SpaceX (SPCX) completed its record-breaking IPO this past week, ending its first day up 19%. Beyond the headline deal, a handful of other sizable IPOs priced, and one major issuer joined the pipeline. Back to the headline: SpaceX priced a full-sized deal at...read more
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, raised $670 million by offering 33.5 million shares at $20, above the $17 to $19 range. The company offered 0.2 million more shares than anticipated. It originally ...read more
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, raised the proposed deal size for its upcoming IPO on Tuesday. The Cambridge, MA-based company now plans to raise $600 million by offering 33.3 million shares at...read more
The IPO market is set to host a historic event in the coming week, with SpaceX (SPCX) set to list on Friday. Beyond the headline offering, a few other sizable IPOs are scheduled to price. SpaceX plans to raise $75 billion by offering 555.6 million shares at...read more
US IPO Weekly Recap: SpaceX completes record-breaking $75 billion IPO and trades up 19%
SpaceX (SPCX) completed its record-breaking IPO this past week, ending its first day up 19%. Beyond the headline deal, a handful of other sizable IPOs priced, and one major issuer joined the pipeline. Back to the headline: SpaceX priced a full-sized deal at...read more
Cancer biotech Parabilis Medicines prices further upsized IPO at $20, above the range
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, raised $670 million by offering 33.5 million shares at $20, above the $17 to $19 range. The company offered 0.2 million more shares than anticipated. It originally ...read more
Cancer biotech Parabilis Medicines ups shares offered by 33% ahead of $600 million IPO
Parabilis Medicines, a clinical-stage biotech developing engineered peptide therapies for cancer, raised the proposed deal size for its upcoming IPO on Tuesday. The Cambridge, MA-based company now plans to raise $600 million by offering 33.3 million shares at...read more
US IPO Week Ahead: SpaceX counts down to its historic $75 billion IPO
The IPO market is set to host a historic event in the coming week, with SpaceX (SPCX) set to list on Friday. Beyond the headline offering, a few other sizable IPOs are scheduled to price. SpaceX plans to raise $75 billion by offering 555.6 million shares at...read more